Evaluation of Belzutifan in Patients with Tumors Associated with Von Hippel-Lindau Disease: A Retrospective Analysis from a Single Center - Top-Institutions - MDSpire

Evaluation of Belzutifan in Patients with Tumors Associated with Von Hippel-Lindau Disease: A Retrospective Analysis from a Single Center

  • By

  • Kilian Rhein

  • Fruzsina Kotsis

  • Athina Ganner

  • Sophie Astheimer

  • Christine Julia Gizaw

  • Yannik Laich

  • Cordula Annette Jilg

  • Jan-Helge Klingler

  • Elke Neumann-Haefelin

  • November 1, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Medical Oncology
    • Genetics
    • Translational Research

  • #2

    University Medical Center Freiburg - VHL Center
    University Medical Center Freiburg - VHL Center

    Freiburg, Baden-Württemberg, Germany

    Key Differentiators

    • Medical Oncology
    • Neurosurgery
    • Genetics
    • Multidisciplinary Care

  • #3

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Medical Oncology
    • Genetics
    • Urology

  • #4

    Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital Cancer Center

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Genetics
    • Neurosurgery

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Medical Oncology
    • Genetics
    • Neurosurgery

Original Source(s)

Evaluation of Belzutifan in Patients with Tumors Associated with Von Hippel-Lindau Disease: A Retrospective Analysis from a Single Center

  • by Kilian Rhein, Fruzsina Kotsis, Athina Ganner, Sophie Astheimer, Christine Julia Gizaw, Yannik Laich, Cordula Annette Jilg, Jan-Helge Klingler, Elke Neumann-Haefelin

  • November 1, 2025

Related Content

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Fabricated Citations Are Reaching Medical Journals

A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.

Distress Screening in a Cancer Survivorship Clinic: Impact on Psychosocial Referrals

This quality improvement project found that using a distress screening tool for head and neck cancer patients who were 2 or more years post-treatment led to an increased number of referrals for psychosocial needs.